Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bergamaschi

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Haematologica|July 1, 1990
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons]M Cazzola, P Pedrazzoli, G Bergamaschi, et al.
Cancer Investigation|January 1, 1994
Effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on small cell lung cancer cellsP Pedrazzoli, G Bacciocchi, G Bergamaschi, et al.
Haematologica|September 1, 1996
Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancyM Cazzola, L Ponchio, C Pedrotti, et al.
Leukemia|January 1, 1988
Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syndromesC Carlo Stella, M Cazzola, A Ganser, et al.
Leukemia|February 1, 1989
Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studiesL Dezza, M Cazzola, M Danova, et al.
Haematologica|May 1, 1984
Clinical evaluation of erythrocyte zinc-protoporphyrin as a parameter of iron status in manV Bellotti, G Bergamaschi, D Caldera, et al.
Blood|July 15, 1997
Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNAM Cazzola, G Bergamaschi, L Tonon, et al.
Blood|January 1, 1992
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trialM Cazzola, L Ponchio, Y Beguin, et al.
Blood|November 1, 1983
Biologic and clinical significance of red cell ferritinM Cazzola, L Dezza, G Bergamaschi, et al.
Leukemia|January 1, 1994
Idarubicin-containing regimen and G-CSF are capable of recruiting CD34+/DR- cells with high proliferative potential which sustain Ph-negative polyclonal hematopoiesisA M Carella, M Podestá, N Pollicardo, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Haematologica|July 1, 1990
[Pathogenetic mechanisms of chronic myeloid leukemia and the antiproliferative effects of alpha and gamma interferons]M Cazzola, P Pedrazzoli, G Bergamaschi, et al.
Cancer Investigation|January 1, 1994
Effects of granulocyte-macrophage colony-stimulating factor and interleukin-3 on small cell lung cancer cellsP Pedrazzoli, G Bacciocchi, G Bergamaschi, et al.
Haematologica|September 1, 1996
Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancyM Cazzola, L Ponchio, C Pedrotti, et al.
Leukemia|January 1, 1988
Recombinant gamma-interferon induces in vitro monocytic differentiation of blast cells from patients with acute nonlymphocytic leukemia and myelodysplastic syndromesC Carlo Stella, M Cazzola, A Ganser, et al.
Leukemia|February 1, 1989
Effects of desferrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studiesL Dezza, M Cazzola, M Danova, et al.
Haematologica|May 1, 1984
Clinical evaluation of erythrocyte zinc-protoporphyrin as a parameter of iron status in manV Bellotti, G Bergamaschi, D Caldera, et al.
Blood|July 15, 1997
Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNAM Cazzola, G Bergamaschi, L Tonon, et al.
Blood|January 1, 1992
Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trialM Cazzola, L Ponchio, Y Beguin, et al.
Blood|November 1, 1983
Biologic and clinical significance of red cell ferritinM Cazzola, L Dezza, G Bergamaschi, et al.
Leukemia|January 1, 1994
Idarubicin-containing regimen and G-CSF are capable of recruiting CD34+/DR- cells with high proliferative potential which sustain Ph-negative polyclonal hematopoiesisA M Carella, M Podestá, N Pollicardo, et al.
Pageof 9